Federal contract award
W81XWH22C0040
R&D DHA PHASE II SBIR MONTHS 1-23 FOR PROJECT TITLED, "NOVEL BIOLOGIC COUNTERMEASURE FOR ACUTE RADIATION SYNDROME".
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | ARMY MED RES ACQ ACTIVITY |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | SMALL BUSINESS SET ASIDE - TOTAL |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $3.0M |
| Current contract value | $3.0M |
| Potential contract value / ceiling | $3.0M |
| Start date | Jun 21, 2022 |
| Current end date | Oct 20, 2026 |
| Potential end date | Oct 20, 2026 |
| Latest award activity | Aug 12, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 12, 2025 | P00002 | $0 | DEFENSE HEALTH AGENCY PHASE II SBIR FOR PROJECT TITLED, NOVEL BIOLOGIC COUNTERMEASURE FOR ACUTE RADIATION SYNDROME |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.